Aranesp (darbepoetin alfa) injection

Aranesp is a prescription medicine used for the treatment of anemia. Brand Name: Aranesp (darbepoetin alfa) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2001

Home | darbepoetin alfa injection

Aranesp (darbepoetin alfa) injection Price In India and Overseas
Aranesp (darbepoetin alfa) injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Aranesp (darbepoetin alfa) injection

Darbepoetin may be used for patients on kidney dialysis or for those not on dialysis. Anemia can also occur in people who are receiving chemotherapy to treat cancer. Darbepoetin alfa is used to treat severe anemia in these patients. This medicine is available only with your doctor's prescription.

Aranesp is an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia due to:
• Chronic Kidney Disease (CKD) in patients on dialysis and patients not on dialysis.
• The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.

Darbepoetin alfa medication was approved in September 2001, by the US Food and Drug Administration for treatment of anemia in patients with chronic kidney failure by intravenous or subcutaneous injection. In June 2001, it had been approved by the European Medicines Agency for this indication as well as the treatment of anemia in cancer patients undergoing chemotherapy.

Drug (Brand / Generic): Aranesp / darbepoetin alfa
Current Indications: anemia
Marketed by:: Amgen Medical Information
Approval Date: 2001

Dosage forms and strengths of Aranesp (darbepoetin alfa) injection
• Single-dose vials: 25, 40, 60, 100, 200, 300, and 500 mcg/1 mL, and 150 mcg/0.75 mL
• Single-dose prefilled syringes: 25 mcg/0.42mL, 40 mcg/,0.4mL, 60 mcg/0.3 mL, 100 mcg/0.5 mL, 150 mcg

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.